Rotavirus in Ireland: national estimates of disease burden, 1997 to 1998

被引:27
作者
Lynch, M
O'Halloran, F
Whyte, D
Fanning, S
Cryan, B
Glass, RI
机构
[1] CDCP, Viral Gastroenteritis Sect, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[2] Cork Univ Hosp, Dept Med Microbiol, Cork, Ireland
[3] Cork Inst Technol, Bishopstown, Ireland
[4] Sir Patrick Duns Hosp, Natl Dis Surveillance Ctr, Dublin, Ireland
关键词
rotavirus; diarrhea; hospitalizations; epidemiology;
D O I
10.1097/00006454-200107000-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We estimated the disease burden caused by rotavirus hospitalizations in the Republic of Ireland by using national data on the number of hospitalizations for diarrhea in children and laboratory surveillance of confirmed rotavirus detections. Methods. We examined trends in diarrheal hospitalizations among children <5 years old as coded by ICD-9-CM for the period January, 1997, to December, 1998. We collated data on laboratory-confirmed rotavirus detections nationally for the same period among children <2 years old. We calculated the overall contribution of rotavirus to laboratory-confirmed intestinal disease in children <5 years old from INFOSCAN, a disease bulletin for one-third of the population. We compared data from all sources and estimated the proportion of diarrheal hospitalizations that are likely the result of rotavirus in children <5 years old. Results. In children <5 years old, 9% of all hospitalizations are for diarrheal illness. In this age group 1 in 8 are hospitalized for a diarrheal illness, and 1 in 17 are hospitalized for rotavirus by 5 years of age. In hospitalized children <2 years old, 1 in 38 have a laboratory confirmed rotavirus infection. Conclusions. The disease burden of rotavirus hospitalizations is higher than in other industrialized countries. Access to comprehensive national databases may have contributed to the high hospitalization rates, as well as a greater tendency to hospitalize children with diarrhea in Ireland.
引用
收藏
页码:693 / 698
页数:6
相关论文
共 17 条
[1]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[2]   Occurrence and impact of community-acquired and nosocomial rotavirus infections - a hospital-based study over 10 y [J].
Berner, R ;
Schumacher, RF ;
Hameister, S ;
Forster, J .
ACTA PAEDIATRICA, 1999, 88 :48-52
[3]   Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial [J].
Bernstein, DI ;
Sack, DA ;
Rothstein, E ;
Reisinger, K ;
Smith, VE ;
O'Sullivan, D ;
Spriggs, DR ;
Ward, RL .
LANCET, 1999, 354 (9175) :287-290
[4]  
*CENTR STAT OFF, 1996, IR CENS POP 1996, V2
[5]   The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants [J].
Clark, HF ;
Offit, PA ;
Ellis, RW ;
Eiden, JJ ;
Krah, D ;
Shaw, AR ;
Pichichero, M ;
Treanor, JJ ;
Borian, FE ;
Bell, LM ;
Plotkin, SA .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S73-S80
[6]  
CRYAN B, 1996, INFOSCAN, V6, P3
[7]   Hospitalisations for rotavirus gastroenteritis among children under five years of age in New South Wales [J].
Ferson, MJ .
MEDICAL JOURNAL OF AUSTRALIA, 1996, 164 (05) :273-276
[8]   The epidemiology of rotavirus diarrhea in the United States: Surveillance and estimates of disease burden [J].
Glass, RI ;
Kilgore, PE ;
Holman, RC ;
Jin, SX ;
Smith, JC ;
Woods, PA ;
Clarke, MJ ;
Ho, MS ;
Gentsch, JR .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S5-S11
[9]   Epidemiology of rotavirus infections in the Netherlands [J].
Koopmans, M ;
Van Asperen, I .
ACTA PAEDIATRICA, 1999, 88 :31-37
[10]  
LYNCH M, 1998, INFOSCAN, V8, P2